ICE/Caspase-1 inhibitors as novel anti-inflammatory drugs von Randle, John CR, Harding, Matthew W, Ku, George, Schönharting, Martin, Kurrle, Roland

Volltext

Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes von Schulte, T, Kurrle, R, Röllinghoff, M, Gessner, A

Volltext

Malononitrilamides: a New Strategy of Immunosuppression for Allo- and Xenotransplantation von Schorlemmer, H., Bartlett, R., Kurrle, R.

Volltext

Malononitrilamides inhibit T- and B-cell responsiveness in different species von Kurrle, R., Ruuth, E., Bartlett, R., Lauffer, L., Schorlemmer, H.U.

Volltext

Disease-modifying activity of malononitrilamides, derivatives of leflunomide's active metabolite, on models of rheumatoid arthritis von Schorlemmer, H U, Kurrle, R, Schleyerbach, R, Bartlett, R R

Volltext

The antiproliferative effect of malononitrilamides (MNAs) on vascular smooth muscle cells is antagonized by exogenous uridine von Czech, J, Kurrle, R, Schorlemmer, H U

Volltext

Activation signals in human lymphocytes. Incorporation of polyunsaturated fatty acids into plasma membrane phospholipids regulates IL-2 synthesis via sustained activation of protei... von Szamel, M, Rehermann, B, Krebs, B, Kurrle, R, Resch, K

Volltext

The Type II IL-1 Receptor Interacts with the IL-1 Receptor Accessory Protein: A Novel Mechanism of Regulation of IL-1 Responsiveness von Lang, Detlef, Knop, Johannes, Wesche, Holger, Raffetseder, Ute, Kurrle, Roland, Boraschi, Diana, Martin, Michael U

Volltext

Generation of O2- radicals in macrophages can be inhibited in vitro and in vivo by derivatives of leflunomide's primary metabolite von Schorlemmer, H U, Kurrle, R, Schleyerbach, R, Bartlett, R R

Volltext

Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis von BANDA, N. K, BERNIER, J, KURAHARA, D. K, KURRLE, R, HAIGWOOD, N, SEKALY, R.-P, FINKEL, T. H

Volltext

Analogues of leflunomide's primary metabolite, the malononitrilamides, prevent the development of graft-versus-host disease von Schorlemmer, H.U., Bartlett, R.R., Kurrle, R.

Volltext

Malononitrilamides Reduce IgM and IgG Xenoantibodies and Prolong Skin Xenograft Survival in a Mouse-to Rat Model von Schorlemmer, H.U., Kurrle, R.

Volltext

Generation of O 2 - radicals in macrophages can be inhibited in vitro and in vivo by derivatives of leflunomide's primary metabolite von Schorlemmer, H. U., Kurrle, R., Schleyerbach, R., Bartlett, R. R.

Volltext

Various graft vs. host diseases (GvHD) in rodents can be prevented and treated by malononitrilamides (MNAs) von Schorlemmer, H U, Kurrle, R, Bartlett, R R

Volltext

Combination therapy of malononitrilamides and tacrolimus (FK 506) induced long-term xenograft survival von Schorlemmer, H.U, Kurrle, R

Volltext

Long-term xenograft survival by combination therapy of malononitrilamide MNA 715 with cyclosporine von Schorlemmer, H.U., Kurrle, R.

Volltext

In vivo lymphoproliferation in the popliteal lymph node (PLN) assay can be inhibited by leflunomide's active metabolite A77 1726 von Schorlemmer, H U, Kurrle, R, Schleyerbach, R, Bartlett, R R

Volltext

Hyperacute Skin Allograft Rejection in Presensitized Rats Is Abrogated by Malononitrilamides von Schorlemmer, H.U., Kurrle, R.

Volltext

The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model von Schorlemmer, H.U., Kurrle, R.

Volltext

Regulation of alloreactivity in the popliteal lymph node assay by the new immunosuppressants: malononitrilamides von Schorlemmer, H U, Ruuth, E, Kurrle, R

Volltext